Overview

Price chart · mood · technical indicators

CMPS

Compass Pathways Plcstock Healthcare

Medical Care Facilities

$9.52161.18%Current Market Mood:Strong Bullish

Market Mood

Price Range (1Y)

$2.25$10.21

Current: $9.52

Market Comparison

vs Healthcare Sector & Medical Care Facilities Industry

CMPS

+161.18%

1Y Performance

Healthcare

Sector 1Y

Medical Care Facilities

Industry 1Y

Fundamentals

Updated daily after market close

P/E ratio—

EPS (TTM)$-3.080.0% YoY

Profit margin0.0%HEALTHCARE

Market cap$1.22BSmall cap

Wall Street coverage

$21.43median target· current $8.61 (+148.9%)13 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E: —
PEG ratio: —
P/B: 16.11
P/S (TTM): —
EV/EBITDA: -3.51

Profitability & growth

ROE (TTM): -565.0%
Operating margin: 0.0%
Revenue growth YoY: 0.0%
Dividend yield: —
Beta: 2.40

Last earnings

Feb 26, 2026 · Estimate $-0.40 · Reported $-0.61

Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

50 articles · sorted by date

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Compass Pathways Plc

Company profile

COMPASS Pathways plc is a mental health care company in the United Kingdom and the United States. The company is headquartered in Cheshire, the United Kingdom.

Classification

Sector: Healthcare
Industry: Medical Care Facilities
Exchange: NASDAQ
Country: USA
Currency: USD

Company profile

HQ: 33 BROADWICK STREET, LONDON, UNITED KINGDOM
Fiscal year end: December
Latest quarter: Dec 31, 2025

Market cap$1.22B

Shares outstanding$134.9M

52W high$10.21

52W low$2.25

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer

Overview

CMPS

Market Comparison

Fundamentals

Wall Street coverage

Valuation

Profitability & growth

News & Sentiment

Jefferies initiates Compass Pathways stock with buy on depression drug By Investing.com

BIT Capital GmbH Raises Stock Holdings in Compass Pathways PLC Sponsored ADR $CMPS

Compass Pathways psilocybin asset for depression awarded commissioner voucher

Compass Pathways psilocybin asset for depression awarded commissioner voucher

CMPS Soars As Compass Pathways Rides Psychedelic Policy Wave

Biopharmaceutical company COMPASS Pathways plc announced that the U.S. Food and Drug Administration (FDA) has officially approved its request for rolling review of its New Drug Application (NDA), and has simultaneously granted a priority review vouch

Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher

Biopharmaceutical company COMPASS Pathways plc announced that the U.S. Food and Drug Administration (FDA) has officially approved its request for rolling review of its New Drug Application (NDA), and has simultaneously granted a priority review vouch

Compass Pathways (NASDAQ:CMPS) Stock Price Up 7.7% - Here's What Happened

How much upside is left in COMPASS Pathways (CMPS)? Wall Street analysts think 136%

Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments

Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments

Compass Pathways partners with Osmind on psychedelic treatment delivery

COMPASS Pathways Stock Rallies 50% Following Trump Executive Order on Psychedelic Research

Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026

COMPASS Pathways (CMPS) Stock Jumps 25% After Trump Signs Psychedelics Executive Order

Nektar Therapeutics, Compass Pathways, Sila Realty Trust And Other Big Stocks Moving Higher On Monday

The Federal Move That Sent Psychedelics Stocks Flying

Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026

Compass Pathways CEO joins April 27 panel on scaling psychedelics

About Compass Pathways Plc

Classification

Company profile

CMPS

Market Comparison

CMPS Market Analysis

Overview

CMPS

Market Comparison

Fundamentals

Wall Street coverage

Valuation

Profitability & growth

News & Sentiment

Jefferies initiates Compass Pathways stock with buy on depression drug By Investing.com

BIT Capital GmbH Raises Stock Holdings in Compass Pathways PLC Sponsored ADR $CMPS

Compass Pathways psilocybin asset for depression awarded commissioner voucher

Compass Pathways psilocybin asset for depression awarded commissioner voucher

CMPS Soars As Compass Pathways Rides Psychedelic Policy Wave

Biopharmaceutical company COMPASS Pathways plc announced that the U.S. Food and Drug Administration (FDA) has officially approved its request for rolling review of its New Drug Application (NDA), and has simultaneously granted a priority review vouch

Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher

Biopharmaceutical company COMPASS Pathways plc announced that the U.S. Food and Drug Administration (FDA) has officially approved its request for rolling review of its New Drug Application (NDA), and has simultaneously granted a priority review vouch

Compass Pathways (NASDAQ:CMPS) Stock Price Up 7.7% - Here's What Happened

How much upside is left in COMPASS Pathways (CMPS)? Wall Street analysts think 136%

Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments

Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments

Compass Pathways partners with Osmind on psychedelic treatment delivery

COMPASS Pathways Stock Rallies 50% Following Trump Executive Order on Psychedelic Research

Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026

COMPASS Pathways (CMPS) Stock Jumps 25% After Trump Signs Psychedelics Executive Order

Nektar Therapeutics, Compass Pathways, Sila Realty Trust And Other Big Stocks Moving Higher On Monday

The Federal Move That Sent Psychedelics Stocks Flying

Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026

Compass Pathways CEO joins April 27 panel on scaling psychedelics

About Compass Pathways Plc

Classification

Company profile

CMPS

Market Comparison